Atlas Trials

Entero Therapeutics

10 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Entero Therapeutics

RecordFirmDate
Study to Assess an Enteric Microgranule Formulation of Adrulipase in Patients With Cystic Fibrosis (NCT05719311)Entero Therapeutics2023-02-01
Niclosamide In Moderate COVID-19 (NCT04436458)Entero Therapeutics2022-01-20
Niclosamide in COVID-19 (NCT04542434)Entero Therapeutics2022-01-20
Safety and Efficacy of Niclosamide in Patients With COVID-19 With Gastrointestinal Infection (NCT04858425)Entero Therapeutics2021-04-30
Study of Latiglutenase in T1D/CD Patients (NCT04839575)Entero Therapeutics2021-04-06
OPTION 2: A Trial to Assess the Safety and Efficacy of MS1819 in Enteric Capsules in Patients With Cystic Fibrosis (NCT04375878)Entero Therapeutics2020-07-20
Prospective, Randomized, Double-Blind, Placebo-Controlled, Crossover Study in Symptomatic CD Patients (NCT04243551)Entero Therapeutics2019-11-01
OPTION: A Trial to Assess the Safety & Efficacy of MS1819 in Patients With Exocrine Pancreatic Insufficiency Due to Cystic Fibrosis (NCT03746483)Entero Therapeutics2019-01-10
A Study of Niclosamide Enemas in Subjects With Active Ulcerative Proctitis or Ulcerative Proctosigmoiditis (NCT03521232)Entero Therapeutics2018-05-15

Track Entero Therapeutics automatically

Every clearance here is in the API, with alerts when new ones post.